4
Changes in Ownership
Stoke Therapeutics, Inc. Filed Acc 0001966716-25-000008
GENERAL COUNSEL & CORP SEC sold 9,803 shares at an average $31.25 ($306,322)
- GENERAL COUNSEL & CORP SEC acquired 6,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Allan Jonathan GENERAL COUNSEL & CORP SEC | 2025-12-03 | Option exercise 10b5-1 | +6,000 | 25,612 | D: show line 1 in the form | ||
| Allan Jonathan GENERAL COUNSEL & CORP SEC | 2025-12-04 | Sale 10b5-1 | −824 | $30.76 | $25,349 | 24,788 | D: show line 2 in the form |
| Allan Jonathan GENERAL COUNSEL & CORP SEC | 2025-12-04 | Sale 10b5-1 | −194 | $31.32 | $6,075 | 24,594 | D: show line 3 in the form |
| Allan Jonathan GENERAL COUNSEL & CORP SEC | 2025-12-05 | Sale 10b5-1 | −1,004 | $31.33 | $31,456 | 23,590 | D: show line 4 in the form |
| Allan Jonathan GENERAL COUNSEL & CORP SEC | 2025-12-05 | Sale 10b5-1 | −5,437 | $31.08 | $168,997 | 18,153 | D: show line 5 in the form |
| Allan Jonathan GENERAL COUNSEL & CORP SEC | 2025-12-05 | Sale 10b5-1 | −2,344 | $31.76 | $74,445 | 15,809 | D: show line 6 in the form |
| Open-market sales · 9,803 sh · avg $31.25 · $306,322 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Allan Jonathan GENERAL COUNSEL & CORP SEC | 2025-12-03 | Option exercise · Performance Stock Units 10b5-1 | −6,000 | 0 | D: show line 7 in the form |
Loading xslF345X05/form4-12062025_011219.xml…